Laboratorios Bagó adopts artificial intelligence in research, production and quality control
Edgardo Vázquez, general manager of Laboratorios Bagó, said at Infobae Talks Salud that the company uses artificial intelligence predictive models to shorten the development times of new drugs and narrow down research options. The firm also applies these tools in production and quality control under an industry 4.0 scheme, with simultaneous rather than sequential processes. In addition, data analysis helps connect providers, laboratories and patients and optimize resources in the Argentine healthcare system.
In 35 seconds
- Bagó uses AI predictive models to shorten drug development times and narrow down research options.
- The pharmaceutical company applies AI in production and quality control under an industry 4.0 scheme, with simultaneous processes.
- Data analysis aims to connect providers, laboratories and patients and optimize the use of healthcare resources.
IASummary generated by artificial intelligence from a story by Diario del Sur. It may contain errors: the original source prevails.





Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.